Akiyoshi T, Kawaguchi M, Tsuji H
Gan. 1978 Feb;69(1):57-60.
By the use of the indirect migration inhibition technique blocking or inhibitory effect of autologous plasma on the production of migration inhibitory factor (MIF) from lymphocytes contacted with autologous tumor extract was studied in 45 patients with malignant tumor. When autologous plasma was added to the lymphocyte culture incubated with autologous tumor extract in 44 of these patients, inhibition of migration was completely abrogated in 9 of these patients whose lymphocytes produced MIF when cultured in plasma-free medium. MIF activity was not abolished when autologous plasma was added to the supernatant of lymphocyte culture incubated with autologous tumor extract. Inhibition of migration was not affected by the addition of allogeneic plasma from a normal subject to the lymphocyte culture. In 15 patients, MIF was not produced when lymphocytes were cultured with autologous plasma alone. These results appeared to indicate that autologous plasma of patients with malignant tumor might block or inhibit the production of MIF from lymphocytes contacted with autologous tumor extract.
采用间接迁移抑制技术,对45例恶性肿瘤患者自体血浆对与自体肿瘤提取物接触的淋巴细胞产生迁移抑制因子(MIF)的阻断或抑制作用进行了研究。在这些患者中的44例中,当将自体血浆添加到与自体肿瘤提取物一起培养的淋巴细胞培养物中时,在9例淋巴细胞在无血浆培养基中培养时产生MIF的患者中,迁移抑制完全被消除。当将自体血浆添加到与自体肿瘤提取物一起培养的淋巴细胞培养物的上清液中时,MIF活性并未被消除。向淋巴细胞培养物中添加正常受试者的异体血浆对迁移抑制没有影响。在15例患者中,淋巴细胞单独与自体血浆培养时不产生MIF。这些结果似乎表明,恶性肿瘤患者的自体血浆可能会阻断或抑制与自体肿瘤提取物接触的淋巴细胞产生MIF。